Asia
Alphamab Oncology, based in Suzhou, China, inked a collaboration deal with Sanofi (China) Investment Co. to advance clinical trials of Alphamab’s KN026 with Sanofi’s Taxotere (docetaxel) in HER2+ breast cancer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 8, 2020.
Roxadustat was non-inferior to Aranesp in hemoglobin levels during the first 24 weeks of treatment, which was the trial’s primary endpoint.
As summer begins, we’re seeing a shift away from COVID-19-related news and a stronger output of other clinical trial news. Here’s a look.
Daiichi Sankyo announced on May 28 that it had entered an agreement with Syneos Health to form a coalition dedicated to bringing new cancer therapies to patients in a safe and effective manner.
The $7.4 billion raised would fund Gavi’s immunization programs between 2021 and 2025, which would help immunize 300 million children and potentially save 7 to 8 million lives.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 2, 2020.
The American Society of Clinical Oncology 2020 meeting was held virtually this year due to the COVID-19 pandemic. As usual, there were literally hundreds of abstracts, posters and presentations. Here’s a look at some of the highlights.
In the lead-up to the ASCO Annual Meeting, companies were presenting some of their trial data, while other companies were presenting news related to COVID-19 studies. Here’s a look.
Numerous biopharmaceutical companies and researchers are presenting research and clinical trial results, and many have been announcing their plans for several weeks.
PRESS RELEASES